Research programme: thrombosis therapy - Medicure
Alternative Names: MC 45228; MC-45308Latest Information Update: 04 Nov 2017
At a glance
- Originator Medicure
- Class Pyridines; Small molecules
- Mechanism of Action Platelet aggregation inhibitors; Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes - Thrombosis
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Thrombosis in Canada
- 25 Jan 2012 Research programme: thrombosis therapy - Medicure is still available for licensing. http://www.medicure.com
- 02 Dec 2010 Research programme: thrombosis therapy - Medicure is still available for licensing. http://www.medicure.com